Screening Platform
Source: Aurora Biosciences Corporation
An integral part of the UHTSS is the Nanoplate, which is a screening platform that has 3,456 miniaturized wells in
An integral part of the UHTSS is the Nanoplate, which is a screening platform that has 3,456 miniaturized wells in which fluorescent assay screens may be performed. A key feature of this product is the small assay volume, approximately 100 times smaller than most conventional screening assays. This reduction in volume is important for reducing the cost per test and conserving compound libraries that often consist of only very small amounts of each test compound. These plates have been designed to work with most of the company's fluorescent assay technologies and other sensitive fluorescent assays.
Aurora Biosciences Corporation, 11010 Torreyana Rd., San Diego, CA 92121 Phone: (619) 404-6600 Fax: (619) 404-6714
This website uses cookies to ensure you get the best experience on our website. Learn more